33 recently arrived companies create hundreds of jobs The efforts of BaselArea.swiss proved extremely successful in 2018. 33 companies – seven more than…Jérémie Meyer03.28.2019
“We ease the transition from analogue to digital for every company” | News 05.11.2019 "We ease the transition from analogue to digital for every company" Which…03.04.2019
“We want to empower life scientists with accessible automation they can use every day” | News 05.11.2019Which problem does your company aim to solve? Oskari Vinko, UniteLabs AG: Companies are…03.04.2019
“It’s a great reward, especially for the team” | News 05.11.2019Which problem does your company aim to solve? Yann Duscher, Crevoisier: Crevoisier wants to…03.01.2019
“We have been building Industry 4.0 for more than 20 years. Except that it wasn’t called that way” | News 05.11.2019Which problem does your company aim to solve? David Maître, LCB: LCB is a…03.01.2019
“Industry 4.0 brings intelligence to machines and processes” | News 05.11.2019Which problem does your company aim to solve? Jean-Marie Dubois, qiio AG: Most of…03.01.2019
Anaveon raises CHF 35 million Anaveon, an immuno-oncology biotech, has successfully concluded a Series A financing round led by Syncona,…Jérémie Meyer02.26.2019
Infographic: The Basel Biotech & Pharma Ecosystem To develop a scientific discovery into a life-changing drug or technology, it takes experts from…Jérémie Meyer01.07.2019
Resistell closes successful financing round Resistell has closed on oversubscribed seed financing round. The Basel-based startup is developing an antibiotic…Jérémie Meyer12.11.2018
BaselArea.swiss fights antimicrobial resistance as a part of the CARB-X Global Accelerator Network Antibiotic resistance is fatal: If antibiotics have no effect, simple infections become deadly. According to…Jérémie Meyer12.04.2018